📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

Rapport Therapeutics Inc (RAPP)

NASDAQ
Currency in USD
Disclaimer
20.84
+1.83(+9.63%)
Closed
After Hours
20.840.00(0.00%)
RAPP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
19.1521.80
52 wk Range
16.5528.08
Prev. Close
19.01
Open
19.15
Day's Range
19.15-21.8
52 wk Range
16.55-28.08
Volume
199,239
Average Vol. (3m)
137,487
1-Year Change
-
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
RAPP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
35.00
Upside
+67.95%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Rapport Therapeutics Inc Company Profile

Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.

Compare RAPP to Peers and Sector

Metrics to compare
RAPP
Peers
Sector
Relationship
P/E Ratio
−12.1x−0.9x−0.6x
PEG Ratio
-−0.020.00
Price / Book
2.3x0.5x2.6x
Price / LTM Sales
-2.9x3.1x
Upside (Analyst Target)
84.1%130.3%57.2%
Fair Value Upside
Unlock11.2%7.3%Unlock

People Also Watch

27.78
TWFG
+1.61%
9.58
LXEO
+0.21%
5.88
BTMD
-2.33%
4.170
INTS
+2.46%

FAQ

What Is the Rapport Therapeutics (RAPP) Stock Price Today?

The Rapport Therapeutics stock price today is 20.84

What Stock Exchange Does Rapport Therapeutics Trade On?

Rapport Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Rapport Therapeutics?

The stock symbol for Rapport Therapeutics is "RAPP."

What Is the Rapport Therapeutics Market Cap?

As of today, Rapport Therapeutics market cap is 695.32M.

What is Rapport Therapeutics Earnings Per Share?

The Rapport Therapeutics EPS is -15.82.

What Is the Next Rapport Therapeutics Earnings Date?

Rapport Therapeutics will release its next earnings report on Nov 27, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.